The molecular biology and novel treatments of vestibular schwannomas

A review

View More View Less
  • 1 Department of Neurological Surgery and
  • 2 Division of Otolaryngology, University of California, Los Angeles; and
  • 3 Department of Neurological Surgery, University of California, San Francisco, California
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Vestibular schwannomas are histopathologically benign tumors arising from the Schwann cell sheath surrounding the vestibular branch of cranial nerve VIII and are related to the NF2 gene and its product merlin. Merlin acts as a tumor suppressor and as a mediator of contact inhibition. Thus, deficiencies in both NF2 genes lead to vestibular schwannoma development. Recently, there have been major advances in our knowledge of the molecular biology of vestibular schwannomas as well as the development of novel therapies for its treatment. In this article the authors comprehensively review the recent advances in the molecular biology and characterization of vestibular schwannomas as well as the development of modern treatments for vestibular schwannoma. For instance, merlin is involved with a number of receptors including the CD44 receptor, EGFR, and signaling pathways, such as the Ras/raf pathway and the canonical Wnt pathway. Recently, merlin was also shown to interact in the nucleus with E3 ubiquitin ligase CRL4DCAF1. A greater understanding of the molecular mechanisms behind vestibular schwannoma tumorigenesis has begun to yield novel therapies. Some authors have shown that Avastin induces regression of progressive schwannomas by over 40% and improves hearing. An inhibitor of VEGF synthesis, PTC299, is currently in Phase II trials as a potential agent to treat vestibular schwannoma. Furthermore, in vitro studies have shown that trastuzumab (an ERBB2 inhibitor) reduces vestibular schwannoma cell proliferation. With further research it may be possible to significantly reduce morbidity and mortality rates by decreasing tumor burden, tumor volume, hearing loss, and cranial nerve deficits seen in vestibular schwannomas.

Abbreviations used in this paper: NF1 = neurofibromatosis Type 1; NF2 = NF Type 2.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Isaac Yang, M.D., Department of Neurological Surgery, University of California, Los Angeles, 695 Charles E. Young Drive South, Gonda 3357, Los Angeles, California 90095-1761. email: iyang@mednet.ucla.edu.

Please include this information when citing this paper: published online July 29, 2011; DOI: 10.3171/2011.6.JNS11131.

  • 1

    Abe T, , Izumiyama H, , Imaizumi Y, , Kobayashi S, , Shimazu M, & Sasaki K, : Staged resection of large hypervascular vestibular schwannomas in young adults. Skull Base 11:199206, 2001

    • Search Google Scholar
    • Export Citation
  • 2

    Agrawal Y, , Clark JH, , Limb CJ, , Niparko JK, & Francis HW: Predictors of vestibular schwannoma growth and clinical implications. Otol Neurotol 31:807812, 2010

    • Search Google Scholar
    • Export Citation
  • 3

    Ahmad Z, , Brown CM, , Patel AK, , Ryan AF, , Ongkeko R, & Doherty JK: Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. Otol Neurotol 31:460466, 2010

    • Search Google Scholar
    • Export Citation
  • 4

    Ammoun S, , Cunliffe CH, , Allen JC, , Chiriboga L, , Giancotti FG, & Zagzag D, : ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Neuro Oncol 12:834843, 2010

    • Search Google Scholar
    • Export Citation
  • 5

    An MM, , Zou Z, , Shen H, , Liu P, , Chen ML, & Cao YB, : Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated metaanalysis. Eur J Clin Pharmacol 66:813821, 2010

    • Search Google Scholar
    • Export Citation
  • 6

    Baek SY, & Kim SU: Proliferation of human Schwann cells induced by neu differentiation factor isoforms. Dev Neurosci 20:512517, 1998

  • 7

    Bai Y, , Liu YJ, , Wang H, , Xu Y, , Stamenkovic I, & Yu Q: Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 26:836850, 2007

    • Search Google Scholar
    • Export Citation
  • 8

    Bari ME, , Forster DM, , Kemeny AA, , Walton L, , Hardy D, & Anderson JR: Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature. Br J Neurosurg 16:284289, 2002

    • Search Google Scholar
    • Export Citation
  • 9

    Battaglia A, , Mastrodimos B, & Cueva R: Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol 27:705712, 2006

    • Search Google Scholar
    • Export Citation
  • 10

    Bernards A, & Gusella JF: The importance of genetic mosaicism in human disease. N Engl J Med 331:14471449, 1994

  • 11

    Bianchi AB, , Hara T, , Ramesh V, , Gao J, , Klein-Szanto AJ, & Morin F, : Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6:185192, 1994

    • Search Google Scholar
    • Export Citation
  • 12

    Bosco EE, , Nakai Y, , Hennigan RF, , Ratner N, & Zheng Y: NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation. Oncogene 29:25402549, 2010

    • Search Google Scholar
    • Export Citation
  • 13

    Bourn D, , Carter SA, , Mason S, , Gareth D, , Evans R, & Strachan T: Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 3:813816, 1994

    • Search Google Scholar
    • Export Citation
  • 14

    Bretcher A, , Edwards K, & Fehon R: ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586599, 2002

  • 15

    Carroll SL, , Miller ML, , Frohnert PW, , Kim SS, & Corbett JA: Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 17:16421659, 1997

    • Search Google Scholar
    • Export Citation
  • 16

    Cayé-Thomasen P, , Borup R, , Stangerup SE, , Thomsen J, & Nielsen FC: Deregulated genes in sporadic vestibular schwannomas. Otol Neurotol 31:256266, 2010

    • Search Google Scholar
    • Export Citation
  • 17

    Cayé-Thomasen P, , Werther K, , Nalla A, , Bøg-Hansen TC, , Nielsen HJ, & Stangerup SE, : VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 26:98101, 2005

    • Search Google Scholar
    • Export Citation
  • 18

    CBTRUS: Central Brain Tumor Registry of the United States 1997 Annual Report Chicago, Central Brain Tumor Registry of the United States, 1998

    • Search Google Scholar
    • Export Citation
  • 19

    CBTRUS: Primary Brain Tumors in the United States: Statistical Report, 1995–1999 Chicago, Central Brain Tumor Registry of the United States, 20022003

    • Search Google Scholar
    • Export Citation
  • 20

    Clark JJ, , Provenzano M, , Diggelmann HR, , Xu N, , Hansen SS, & Hansen MR: The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol 29:846853, 2008

    • Search Google Scholar
    • Export Citation
  • 21

    Cole BK, , Curto M, , Chan AW, & McClatchey AI: Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing. Mol Cell Biol 28:12741284, 2008

    • Search Google Scholar
    • Export Citation
  • 22

    Curto M, , Cole BK, , Lallemand D, , Liu CH, & McClatchey AI: Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177:893903, 2007

    • Search Google Scholar
    • Export Citation
  • 23

    Deacon SW, , Beeser A, , Fukui JA, , Rennefahrt UE, , Myers C, & Chernoff J, : An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 15:322331, 2008

    • Search Google Scholar
    • Export Citation
  • 24

    Evans DG, , Birch JM, , Ramsden RT, , Sharif S, & Baser ME: Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet 43:289294, 2006

    • Search Google Scholar
    • Export Citation
  • 25

    Evans DG, , Huson SM, , Donnai D, , Neary W, , Blair V, & Teare D, : A genetic study of type 2 neurofibromatosis in the United Kingdom. I Prevalance, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841846, 1992

    • Search Google Scholar
    • Export Citation
  • 26

    Fernandez-Valle C, , Gwynn L, , Wood PM, , Carbonetto S, & Bunge MB: Anti-beta 1 integrin antibody inhibits Schwann cell myelination. J Neurobiol 25:12071226, 1994

    • Search Google Scholar
    • Export Citation
  • 27

    Fernandez-Valle C, , Tang Y, , Ricard J, , Rodenas-Ruano A, , Taylor A, & Hackler E, : Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31:354362, 2002

    • Search Google Scholar
    • Export Citation
  • 28

    Ferrara N, , Gerber HP, & LeCouter J: The biology of VEGF and its receptors. Nat Med 9:669676, 2003

  • 29

    Flaiz C, , Ammoun S, , Biebl A, & Hanemann CO: Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma. Brain Pathol 19:2738, 2009

    • Search Google Scholar
    • Export Citation
  • 30

    Flaiz C, , Chernoff J, , Ammoun S, , Peterson JR, & Hanemann CO: PAK kinase regulates Rac GTPase and is a potential target in human schwannomas. Exp Neurol 218:137144, 2009

    • Search Google Scholar
    • Export Citation
  • 31

    Flaiz C, , Utermark T, , Parkinson DB, , Poetsch A, & Hanemann CO: Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells. Glia 56:506515, 2008

    • Search Google Scholar
    • Export Citation
  • 32

    Fucci MJ, , Buchman CA, , Brackmann DE, & Berliner KI: Acoustic tumor growth: implications for treatment choices. Am J Otol 20:495499, 1999

    • Search Google Scholar
    • Export Citation
  • 33

    Giovannini M, , Robanus-Maandag E, , van der Valk M, , Niwa-Kawakita M, , Abramowski V, & Goutebroze L, : Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:16171630, 2000

    • Search Google Scholar
    • Export Citation
  • 34

    Gril B, , Palmieri D, , Bronder JL, , Herring JM, , Vega-Valle E, & Feigenbaum L, : Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 100:10921103, 2008

    • Search Google Scholar
    • Export Citation
  • 35

    Hadfield KD, , Smith MJ, , Urquhart JE, , Wallace AJ, , Bowers NL, & King AT, : Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:62166221, 2010

    • Search Google Scholar
    • Export Citation
  • 36

    Halliday AL, , Sobel RA, & Martuza RL: Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74:248253, 1991

    • Search Google Scholar
    • Export Citation
  • 37

    Hansen MR, , Clark JJ, , Gantz BJ, & Goswami PC: Effects of ErbB2 signaling on the response of vestibular schwannoma cells to gamma-irradiation. Laryngoscope 118:10231030, 2008

    • Search Google Scholar
    • Export Citation
  • 38

    Hansen MR, , Roehm PC, , Chatterjee P, & Green SH: Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia 53:593600, 2006

    • Search Google Scholar
    • Export Citation
  • 39

    Herbst RS: Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59:2 Suppl 2126, 2004

  • 40

    Houshmandi SS, , Emnett RJ, , Giovannini M, & Gutmann DH: The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Mol Cell Biol 29:14721486, 2009

    • Search Google Scholar
    • Export Citation
  • 41

    Hrecka K, , Gierszewska M, , Srivastava S, , Kozaczkiewicz L, , Swanson SK, & Florens L, : Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci U S A 104:1177811783, 2007

    • Search Google Scholar
    • Export Citation
  • 42

    Hughes SC, & Fehon RG: Understanding ERM proteins—the awesome power of genetics finally brought to bear. Curr Opin Cell Biol 19:5156, 2007

    • Search Google Scholar
    • Export Citation
  • 43

    Hung G, , Colton J, , Fisher L, , Oppenheimer M, , Faudoa R, & Slattery W, : Immunohistochemistry study of human vestibular nerve schwannoma differentiation. Glia 38:363370, 2002

    • Search Google Scholar
    • Export Citation
  • 44

    Jääskeläinen J, , Paetau A, , Pyykkö I, , Blomstedt G, , Palva T, & Troupp H: Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases. J Neurosurg 80:541547, 1994

    • Search Google Scholar
    • Export Citation
  • 45

    James MF, , Manchanda N, , Gonzalez-Agosti C, , Hartwig JH, & Ramesh V: The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association. Biochem J 356:377386, 2001

    • Search Google Scholar
    • Export Citation
  • 46

    Johnson JR, , Cohen M, , Sridhara R, , Chen YF, , Williams GM, & Duan J, : Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Clin Cancer Res 11:64146421, 2005

    • Search Google Scholar
    • Export Citation
  • 47

    Kaempchen K, , Mielke K, , Utermark T, , Langmesser S, & Hanemann CO: Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Hum Mol Genet 12:12111221, 2003

    • Search Google Scholar
    • Export Citation
  • 48

    Kissil JL, , Blakeley JO, , Ferner RE, , Huson SM, , Kalamarides M, & Mautner VF, : What's new in neurofibromatosis? Proceedsings from the 2009 NF conference: new frontiers. Am J Med Genet Part A 152A:269283, 2009

    • Search Google Scholar
    • Export Citation
  • 49

    Kissil JL, , Johnson KC, , Eckman MS, & Jacks T: Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 277:1039410399, 2002

    • Search Google Scholar
    • Export Citation
  • 50

    Kissil JL, , Wilker EW, , Johnson KC, , Eckman MS, , Yaffe MB, & Jacks T: Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol Cell 12:841849, 2003

    • Search Google Scholar
    • Export Citation
  • 51

    Kluwe L, & Mautner VF: Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7:20512055, 1998

  • 52

    LaJeunesse DR, , McCartney BM, & Fehon RG: Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J Cell Biol 141:15891599, 1998

    • Search Google Scholar
    • Export Citation
  • 53

    Lallemand D, , Curto M, , Saotome I, , Giovannini M, & McClatchey AI: NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17:10901100, 2003

    • Search Google Scholar
    • Export Citation
  • 54

    Lanman TH, , Brackmann DE, , Hitselberger WE, & Subin B: Report of 190 consecutive cases of large acoustic tumors (vestibular schwannoma) removed via the translabyrinthine approach. J Neurosurg 90:617623, 1999

    • Search Google Scholar
    • Export Citation
  • 55

    Laulajainen M, , Muranen T, , Carpén O, & Grönholm M: Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton. Oncogene 27:32333243, 2008

    • Search Google Scholar
    • Export Citation
  • 56

    Lee DJ, , Westra WH, , Staecker H, , Long D, , Niparko JK, & Slattery WH III: Clinical and histopathologic features of recurrent vestibular schwannoma (acoustic neuroma) after stereotactic radiosurgery. Otol Neurotol 24:650660, 2003

    • Search Google Scholar
    • Export Citation
  • 57

    Li Q, , Nance MR, , Kulikauskas R, , Nyberg K, , Fehon R, & Karplus P, : Self-masking in an intact ERM-merlin protein: an active role for the central apical-helical domain. J Mol Biol 365:14461459, 2007

    • Search Google Scholar
    • Export Citation
  • 58

    Li W, , You L, , Cooper J, , Schiavon G, , Pepe-Caprio A, & Zhou L, : Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 140:477490, 2010

    • Search Google Scholar
    • Export Citation
  • 59

    Lin NU, , Carey LA, , Liu MC, , Younger J, , Come SE, & Ewend M, : Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 26:19931999, 2008

    • Search Google Scholar
    • Export Citation
  • 60

    Linskey ME: Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate. J Neurosurg 93:Suppl 3 9095, 2000

    • Search Google Scholar
    • Export Citation
  • 61

    Linthicum FH Jr, & Brackmann DE: Bilateral acoustic tumors. A diagnostic and surgical challenge. Arch Otolaryngol 106:729733, 1980

  • 62

    Louis DN, , Ramesh V, & Gusella JF: Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5:163172, 1995

    • Search Google Scholar
    • Export Citation
  • 63

    Lu JF, , Bruno R, , Eppler S, , Novotny W, , Lum B, & Gaudreault J: Clinical pharmacokinetics of bevacizumab in patients with solid tumors. Cancer Chemother Pharmacol 62:779786, 2008

    • Search Google Scholar
    • Export Citation
  • 64

    MacCollin M, , Ramesh V, , Jacoby LB, , Louis DN, , Rubio MP, & Pulaski K, : Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55:314320, 1994

    • Search Google Scholar
    • Export Citation
  • 65

    Maitra S, , Kulikauskas RM, , Gavilan H, & Fehon RG: The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling. Curr Biol 16:702709, 2006

    • Search Google Scholar
    • Export Citation
  • 66

    Marchionni MA, , Goodearl AD, , Chen MS, , Bermingham-McDonogh O, , Kirk C, & Hendricks M, : Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362:312318, 1993

    • Search Google Scholar
    • Export Citation
  • 67

    Maurel P, & Salzer JL: Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J Neurosci 20:46354645, 2000

    • Search Google Scholar
    • Export Citation
  • 68

    Mautner VF, , Lindenau M, , Baser ME, , Hazim W, , Tatagiba M, & Haase W, : The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38:880886, 1996

    • Search Google Scholar
    • Export Citation
  • 69

    Mautner VF, , Nguyen R, , Kutta H, , Fuensterer C, , Bokemeyer C, & Hagel C, : Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 12:1418, 2010

    • Search Google Scholar
    • Export Citation
  • 70

    McCall CM, , Miliani de Marval PL, , Chastain PD II, , Jackson SC, , He YJ, & Kotake Y, : Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development. Mol Cell Biol 28:56215633, 2008

    • Search Google Scholar
    • Export Citation
  • 71

    McClatchey A, & Fehon R: Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex. Trends Cell Biol 19:198206, 2009

    • Search Google Scholar
    • Export Citation
  • 72

    McLaughlin ME, , Kruger GM, , Slocum KL, , Crowley D, , Michaud NA, & Huang J, : The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion. Proc Natl Acad Sci U S A 104:32613266, 2007

    • Search Google Scholar
    • Export Citation
  • 73

    Medina PJ, & Goodin S: Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. Clin Ther 30:14261447, 2008

    • Search Google Scholar
    • Export Citation
  • 74

    Mérel P, , Hoang-Xuan K, , Sanson M, , Moreau-Aubry A, , Bijlsma EK, & Lazaro C, : Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13:211216, 1995

    • Search Google Scholar
    • Export Citation
  • 75

    Meyer TA, , Canty PA, , Wilkinson EP, , Hansen MR, , Rubinstein JT, & Gantz BJ: Small acoustic neuromas: surgical outcomes versus observation or radiation. Otol Neurotol 27:380392, 2006

    • Search Google Scholar
    • Export Citation
  • 76

    Moffat DA, & Irving RM: The molecular genetics of vestibular schwannoma. J Laryngol Otol 109:381384, 1995

  • 77

    Moore MJ, , Goldstein D, , Hamm J, , Figer A, , Hecht JR, & Gallinger S, : Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:19601966, 2007

    • Search Google Scholar
    • Export Citation
  • 78

    Morrison H, , Sherman LS, , Legg J, , Banine F, , Isacke C, & Haipek CA, : The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968980, 2001

    • Search Google Scholar
    • Export Citation
  • 79

    Morrison H, , Sperka T, , Manent J, , Giovannini M, , Ponta H, & Herlich P: Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the action of Ras and Rac. Cancer Res 67:520527, 2007

    • Search Google Scholar
    • Export Citation
  • 80

    Morrissey TK, , Levi AD, , Nuijens A, , Sliwkowski M, & Bunge RP: Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci U S A 92:14311435, 1995

    • Search Google Scholar
    • Export Citation
  • 81

    Neff BA, , Welling DB, , Akhmametyeva E, & Chang LS: The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol Neurotol 27:197208, 2006

    • Search Google Scholar
    • Export Citation
  • 82

    Okada T, , Lopez-Lago M, & Giancotti FG: Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 171:361371, 2005

    • Search Google Scholar
    • Export Citation
  • 83

    Okada T, , You L, & Giancotti FG: Shedding light on Merlin's wizardry. Trends Cell Biol 17:222229, 2007

  • 84

    Pearson MA, , Reczek D, , Bretscher A, & Karplus PA: Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101:259270, 2000

    • Search Google Scholar
    • Export Citation
  • 85

    Pelton PD, , Sherman LS, , Rizvi TA, , Marchionni MA, , Wood P, & Friedman RA, : Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene 17:21952209, 1998

    • Search Google Scholar
    • Export Citation
  • 86

    Plotkin SR, , Halpin C, , McKenna MJ, , Loeffler JS, , Batchelor TT, & Barker FG II: Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otol Neurotol 31:11351143, 2010

    • Search Google Scholar
    • Export Citation
  • 87

    Plotkin SR, , Stemmer-Rachamimov AO, , Barker FG II, , Halpin C, , Padera TP, & Tyrrell A, : Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361:358367, 2009

    • Search Google Scholar
    • Export Citation
  • 88

    Propp JM, , McCarthy BJ, , Davis FG, & Preston-Martin S: Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 8:111, 2006

  • 89

    Qian X, , Karpova T, , Sheppard AM, , McNally J, & Lowy DR: E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23:17391748, 2004

    • Search Google Scholar
    • Export Citation
  • 90

    Qiu RG, , Chen J, , McCormick F, & Symons M: A role for Rho in Ras transformation. Proc Natl Acad Sci U S A 92:1178111785, 1995

  • 91

    Rouleau GA, , Merel P, , Lutchman M, , Sanson M, , Zucman J, & Marineau C, : Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515521, 1993

    • Search Google Scholar
    • Export Citation
  • 92

    Ruttledge MH, , Sarrazin J, , Rangaratnam S, , Phelan CM, , Twist E, & Merel P, : Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180184, 1994

    • Search Google Scholar
    • Export Citation
  • 93

    Sainio M, , Zhao F, , Heiska L, , Turunen O, , den Bakker M, & Zwarthoff E, : Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 110:22492260, 1997

    • Search Google Scholar
    • Export Citation
  • 94

    Schuknecht HF: Pathology of the Ear ed 2 Philadelphia, Lea & Febiger, 1993

  • 95

    Scoles DR, , Baser ME, & Pulst SM: A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes. Neurology 47:544546, 1996

    • Search Google Scholar
    • Export Citation
  • 96

    Seizinger BR, , Martuza RL, & Gusella JF: Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644647, 1986

    • Search Google Scholar
    • Export Citation
  • 97

    Shaw RJ, , Paez JG, , Curto M, , Yaktine A, , Pruitt WM, & Saotome I, : The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1:6372, 2001

    • Search Google Scholar
    • Export Citation
  • 98

    Shimizu T, , Seto A, , Maita N, , Hamada K, , Tsukita S, & Tsukita S, : Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain. J Biol Chem 277:1033210336, 2002

    • Search Google Scholar
    • Export Citation
  • 99

    Slattery WH III, , Fisher LM, , Iqbal Z, & Oppenhiemer M: Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects. Otol Neurotol 25:811817, 2004

    • Search Google Scholar
    • Export Citation
  • 100

    Solares CA, & Panizza B: Vestibular schwannoma: an understanding of growth should influence management decisions. Otol Neurotol 29:829834, 2008

    • Search Google Scholar
    • Export Citation
  • 101

    Speck O, , Hughes SC, , Noren NK, , Kulikauskas RM, & Fehon RG: Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity. Nature 421:8387, 2003

    • Search Google Scholar
    • Export Citation
  • 102

    Stangerup SE, , Tos M, , Caye-Thomasen P, , Tos T, , Klökker M, & Thomsen J: Increasing annual incidence of vestibular schwannoma and age at diagnosis. J Laryngol Otol 118:622627, 2004

    • Search Google Scholar
    • Export Citation
  • 103

    Stangerup SE, , Tos M, , Thomsen J, & Caye-Thomasen P: True incidence of vestibular schwannoma?. Neurosurgery 67:13351340, 2010

  • 104

    Strasnick B, , Glasscock ME III, , Haynes D, , McMenomey SO, & Minor LB: The natural history of untreated acoustic neuromas. Laryngoscope 104:11151119, 1994

    • Search Google Scholar
    • Export Citation
  • 105

    Sughrue ME, , Yeung AH, , Rutkowski MJ, , Cheung SW, & Parsa AT: Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. A review. J Neurosurg 114:359366, 2009

    • Search Google Scholar
    • Export Citation
  • 106

    Takahashi K, , Sasaki T, , Mammoto A, , Takaishi K, , Kameyama T, & Tsukita S, : Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 272:2337123375, 1997

    • Search Google Scholar
    • Export Citation
  • 107

    Takahashi K, & Suzuki K: Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp Cell Res 226:214222, 1996

    • Search Google Scholar
    • Export Citation
  • 108

    Tos M, , Charabi S, & Thomsen J: Incidence of vestibular schwannomas. Laryngoscope 109:736740, 1999

  • 109

    Tos M, , Stangerup SE, , Cayé-Thomasen P, , Tos T, & Thomsen J: What is the real incidence of vestibular schwannoma?. Arch Otolaryngol Head Neck Surg 130:216220, 2004

    • Search Google Scholar
    • Export Citation
  • 110

    Tos M, & Thomsen J: Epidemiology of acoustic neuromas. J Laryngol Otol 98:685692, 1984

  • 111

    Tos M, , Thomsen J, & Charabi S: Incidence of acoustic neuromas. Ear Nose Throat J 71:391393, 1992

  • 112

    Trofatter JA, , MacCollin MM, , Rutter JL, , Murrell JR, , Duyao MP, & Parry DM, : A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791800, 1993

    • Search Google Scholar
    • Export Citation
  • 113

    Turner CE: Paxillin interactions. J Cell Sci 113:Pt 23 41394140, 2000

  • 114

    Twist EC, , Ruttledge MH, , Rousseau M, , Sanson M, , Papi L, & Merel P, : The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147151, 1994

    • Search Google Scholar
    • Export Citation
  • 115

    Uesaka T, , Shono T, , Suzuki SO, , Nakamizo A, , Niiro H, & Mizoguchi M, : Expression of VEGF and its receptor genes in intracranial schwannomas. J Neurooncol 83:259266, 2007

    • Search Google Scholar
    • Export Citation
  • 116

    Vadlamudi R, , Adam L, , Talukder A, , Mendelsohn J, & Kumar R: Serine phosphorylation of paxillin by heregulin-beta1: role of p38 mitogen activated protein kinase. Oncogene 18:72537264, 1999

    • Search Google Scholar
    • Export Citation
  • 117

    Vartanian T, , Goodearl A, , Viehöver A, & Fischbach G: Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J Cell Biol 137:211220, 1997

    • Search Google Scholar
    • Export Citation
  • 118

    von Recklinghausen F: Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen Berlin, A. Hirschundel, 1882

  • 119

    Welling DB: Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas). Laryngoscope 108:178189, 1998

    • Search Google Scholar
    • Export Citation
  • 120

    Welling DB, , Guida M, , Goll F, , Pearl DK, , Glasscock ME, & Pappas DG, : Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Hum Genet 98:189193, 1996

    • Search Google Scholar
    • Export Citation
  • 121

    Wilkinson JS, , Reid H, & Armstrong GR: Malignant transformation of a recurrent vestibular schwannoma. J Clin Pathol 57:109110, 2004

  • 122

    Wishart J: Case of tumours in the skull, dura mater, and brain. Edinburg Med Surg J 18:393397, 1822

  • 123

    Wong ET, & Brem S: Taming glioblastoma: targeting angiogenesis. J Clin Oncol 25:47054706, 2007

  • 124

    World Health Organization/National Neurofibromatosis Foundation: Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting. Bull World Health Organ 70:173182, 1992

    • Search Google Scholar
    • Export Citation
  • 125

    Yamakami I, , Kobayashi E, , Iwadate Y, , Saeki N, & Yamaura A: Hypervascular vestibular schwannomas. Surg Neurol 57:105112, 2002

  • 126

    Yeung AH, , Sughrue ME, , Kane AJ, , Tihan T, , Cheung SW, & Parsa AT: Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization. Neurosurg Focus 27:6 E2, 2009

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 669 242 18
Full Text Views 295 25 3
PDF Downloads 198 14 1
EPUB Downloads 0 0 0